These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 21034750
41. Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension. Zhou Y, Tian X, Wang X, Wang Y, Fan R, Wang Y, Feng N, Zhang S, Guo H, Gu X, Jia M, Yin W, Hou Z, Li J, Pei J. Eur J Pharmacol; 2018 Aug 05; 832():129-137. PubMed ID: 29782857 [Abstract] [Full Text] [Related]
42. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs. Liu HT, Zhang HF, Si R, Zhang QJ, Zhang KR, Guo WY, Wang HC, Gao F. Sheng Li Xue Bao; 2007 Oct 25; 59(5):651-9. PubMed ID: 17940706 [Abstract] [Full Text] [Related]
43. κ-Opioid Receptors Improve Vascular Endothelial Dysfunction in Salt-Sensitive Hypertension via PI3K/Akt/eNOS Signaling Pathway. Wu Q, Yang H, Zheng Q, Chen Q, Li X, Guo J. Oxid Med Cell Longev; 2023 Oct 25; 2023():5352959. PubMed ID: 36865348 [Abstract] [Full Text] [Related]
44. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation. Li JG, Benovic JL, Liu-Chen LY. Mol Pharmacol; 2000 Oct 25; 58(4):795-801. PubMed ID: 10999950 [Abstract] [Full Text] [Related]
45. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult. Huang C, Cui Y, Ji L, Zhang W, Li R, Ma L, Xing W, Zhou H, Chen B, Yu J, Zhang H. Pharm Biol; 2013 Apr 25; 51(4):463-73. PubMed ID: 23336403 [Abstract] [Full Text] [Related]
46. Quaternary ammonium salt of U50488H, a new κ-opioid receptor agonist, protects rat heart against ischemia/reperfusion injury. Wang Q, Sun Y, Li J, Xing W, Zhang S, Gu X, Feng N, Zhao L, Fan R, Wang Y, Yin W, Pei J. Eur J Pharmacol; 2014 Aug 15; 737():177-84. PubMed ID: 24855042 [Abstract] [Full Text] [Related]
47. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. Li JG, Luo LY, Krupnick JG, Benovic JL, Liu-Chen LY. J Biol Chem; 1999 Apr 23; 274(17):12087-94. PubMed ID: 10207034 [Abstract] [Full Text] [Related]
48. [Inhibitory effects of kappa-opioid receptor stimulation on cultured myocardial cells]. Yang YL, Wang HX, Yang YH. Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 Nov 23; 18(4):358-61. PubMed ID: 21174814 [Abstract] [Full Text] [Related]
49. A κ-OR Agonist Protects the Endothelial Function Impaired by Hyperuricemia Through Regulating the Akt/eNOS Signal Pathway. Zheng Q, Wu Q, Yang H, Chen Q, Li X, Guo J. Probiotics Antimicrob Proteins; 2022 Aug 23; 14(4):751-759. PubMed ID: 35536506 [Abstract] [Full Text] [Related]
50. kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo. Brown CH, Ludwig M, Leng G. J Neurosci; 1998 Nov 15; 18(22):9480-8. PubMed ID: 9801385 [Abstract] [Full Text] [Related]
51. Pro- and anti-arrhythmic effects of a kappa opioid receptor agonist: a model for the biphasic action of a local hormone in the heart. Yu X, Zhang W, Bian J, Wong TM. Clin Exp Pharmacol Physiol; 1999 Oct 15; 26(10):842-4. PubMed ID: 10549419 [Abstract] [Full Text] [Related]
52. The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Lindholm S, Werme M, Brené S, Franck J. Behav Brain Res; 2001 May 15; 120(2):137-46. PubMed ID: 11182162 [Abstract] [Full Text] [Related]
53. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance. Lutfy K, Doan P, Nguyen M, Weber E. Eur J Pharmacol; 1999 Nov 12; 384(1):1-5. PubMed ID: 10611412 [Abstract] [Full Text] [Related]
54. Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism. Li J, Zhang P, Zhang QY, Zhang SM, Guo HT, Bi H, Wang YM, Sun X, Liu JC, Cheng L, Cui Q, Yu SQ, Kaye AD, Yi DH, Pei JM. Vascul Pharmacol; 2009 Nov 12; 51(2-3):72-7. PubMed ID: 19351568 [Abstract] [Full Text] [Related]
55. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs. Brent PJ. Neuropharmacology; 1993 Aug 12; 32(8):751-60. PubMed ID: 8413839 [Abstract] [Full Text] [Related]
56. κ-opioid receptor activation prevents against arrhythmias by preserving Cx43 protein via alleviation of intracellular calcium. Shi QX, Zhang LJ, Yao Y, Zhang QY, Wang W, Li J, Shang YL, Bi H, Zhang SM, Guo HT, Wang YM, Yu SQ, Yi DH, Bueno FR, Kaye AD, Pei JM. Am J Ther; 2013 Aug 12; 20(5):493-501. PubMed ID: 23011166 [Abstract] [Full Text] [Related]
57. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury. Wang J, Ji SY, Liu SZ, Jing R, Lou WJ. Pharmazie; 2015 Sep 12; 70(9):593-7. PubMed ID: 26492644 [Abstract] [Full Text] [Related]
58. Hydrogen sulfide regulates Na+/H+ exchanger activity via stimulation of phosphoinositide 3-kinase/Akt and protein kinase G pathways. Hu LF, Li Y, Neo KL, Yong QC, Lee SW, Tan BK, Bian JS. J Pharmacol Exp Ther; 2011 Nov 12; 339(2):726-35. PubMed ID: 21865440 [Abstract] [Full Text] [Related]